Search results

Found 188 matches for

The COVID-19 National Diagnostic Research and Evaluation Platform (CONDOR) is accelerating how quickly promising COVID-19 diagnostics make it into real-world use. The platform is evaluating new COVID-19 diagnostics in the settings they will be used, such as in GP surgeries, care homes or hospitals, as well as their performance in laboratory settings.

The Conversation: Why we need to test COVID-19 tests

13 January 2021

During the first peak of the coronavirus pandemic, it became apparent that the processing of the standard COVID-19 test using nasal swab samples, while considered a gold standard, was slow, taking over 24 hours to give results in most cases.

Helping to prioritise rapid COVID-19 testing in UK hospitals

5 January 2021

Working with CONDOR partners the Newcastle In Vitro Diagnostics Co-operative have analysed clinical opinion to pinpoint where rapid COVID-19 testing could have the greatest impact in UK hospitals.

Webinar: Prioritising the evaluation of novel coronavirus diagnostics in the UK

24 June 2020

Are you from a diagnostics company and keen to know more about CONDOR? The NIHR is holding a webinar on Wed 15 July where you can learn how the UK is prioritising and evaluating novel coronavirus IVDs and ensure your diagnostic gets the visibility and support it needs.

CONDOR platform launches